PRAX-628 demonstrated a favorable safety and tolerability profile in healthy volunteers at concentrations more than 15-fold the MES EC50; PRAX-628 predicted therapeutic range at least 3-fold wider. | May 11, 2023
Private Equity Holding AG / Key word: Net Asset Value
Private Equity Holding AG: Net Asset Value as of April 30, 2023
09.05.2023 / 18:00 CET/CEST
Net Asset Value
The issuer is. | May 9, 2023
Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Rating) was the recipient of a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 5,970,000 shares, an increase of 34.2% from the March 15th total of 4,450,000 shares. Approximately 14.4% of the company’s shares are sold short. […]